Cowden syndrome: A rare, but recognisable cancer predisposition disorder [1]

Clinical Oncology

Volumn 17, Issue 5, 2005, Pages 393-

  Adlard, J W ^a  

^a Northern and Yorkshire Clinical Trials and Research Unit   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; RADIOACTIVE IODINE; TAMOXIFEN;

ADULT; BREAST CARCINOMA; CANCER RECURRENCE; CANCER SUSCEPTIBILITY; CASE REPORT; CLEAR CELL CARCINOMA; COWDEN SYNDROME; FEMALE; GENE DELETION; GENETIC PREDISPOSITION; GOITER; HUMAN; KIDNEY CARCINOMA; KIDNEY METASTASIS; LETTER; MACROCEPHALY; MASTECTOMY; NEPHRECTOMY; PAGET NIPPLE DISEASE; PRIORITY JOURNAL; RARE DISEASE; SUBTOTAL THYROIDECTOMY; THYROID CANCER;

ADULT; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAMARTOMA SYNDROME, MULTIPLE; HUMANS; MUTATION; NEOPLASMS, MULTIPLE PRIMARY; PHOSPHORIC MONOESTER HYDROLASES; PTEN PHOSPHOHYDROLASE; TUMOR SUPPRESSOR PROTEINS;

EID: 21644457407     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2005.03.009     Document Type: Letter

References (4)

1. National Institute of Clinical Excellence Clinical guideline 14. Familial breast cancer May 2004
2. A. Antoniou P.D. Pharoah S. Narod et al. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations in case series unselected for family history: A combined analysis of 22 studies Am J Hum Genet 72 2003 1117-1130
3. K.M. Bushby T. Cole J.N. Matthews et al. Centiles for adult head circumference Arch Dis Child 67 1992 1286-1287
4. C. Eng Will the real Cowden syndrome please stand up: Revised diagnostic criteria J Med Genet 37 2000 828-830